One of the most severe health problems, that leads women to multiple Chronic Diseases and is attributed to their hormone decline, is Osteoporosis.
- Osteoporosis affects women 8 times more often than men.
- One in two women over the age of 50 will suffer at least once in her life from a fracture due to osteoporosis.
- Osteoporosis affects 200 million women worldwide each year.
- In menopausal women aged 40 to 60 fractures increase by 10 times, something that doesn’t happen to men.
Common types of fractures a menopausal woman experiences are the following:
Vertebral Fractures, Neck fractures, thighbone fractures, wrist fractures, especially fractures of the distal radius (Colles fracture). Colles fractures οφ the radius are 10 times more common in women 55 years old than in women at the age of 35.
What is osteoporosis
When estrogen and progesterone levels decline in a woman, her bones begin to age very quickly. This association of Hormones and Osteoporosis has been known since 1941.
Regardless of the woman’s age, as soon as she is menopausal, she develops Osteoporosis. As years go by, the intensity of the problem increases.
Bones have their own circle of life and metabolism. A rate of growth, life and death which is determined by Estrogens and Progesterone. The decline of estrogen levels during Menopause means that in the middle of the menstrual cycle Estrogen does not reach peak values for about 48 hours, as it should normally do, for Ovulation. When ovulation doesn’t occur, progesterone cannot be produced and its receptors are not activated to create new bone.
Thus, Osteopenia begins first which gradually results in Osteoporosis.
Estrogen also controls the osteoclastic activity. Osteoclasts are bone cells, which decompose the old, aged bone.
Progesterone, on the other hand, controls the osteoblastic activity. Osteoblasts are bone cells that synthesize new bone.
In the case of bone tissue, progesterone forms new bone, while estrogen disassembles the bone tissue, in order to facilitate the bone remodeling process each month, along to the menstrual cycle.
Osteoporosis and the development of treatments to date.
Until now we knew that the main form of Primary Osteoporosis is “Postmenopausal Osteoporosis” in women, which in turn is due to a lack of estrogen and progesterone. However, many decades have passed without a substantial therapeutic approach to this huge problem.
More specifically, until 1982 there were neither reliable diagnostic methods nor serious treatments. In other words, osteoporosis until then was considered a “normal” consequence of “old” people (elderly people), who “as soon as they fall, their bones break”.
In fact, at that time, very few calcium supplements, vitamin D3 combinations, and Alfacalcidol preparations (vitamin D3 metabolite) were commercially available.
However, a very important event that occurred at the same time led to a large international funding of research on this major problem of Osteoporosis. It was nothing more than the appearance of osteoporosis in American and Soviet astronauts – long-time cosmonauts, which developed after spending many months in Skylab (NASA) and Mir (USSR) space stations, respectively.
The results, however, of all synthetic-chemical treatments developed, were and seem to be insufficient. On the one hand, due to their various and multiple side effects, resulting these treatments to be not well tolerated by patients, on the other hand, due to the lack of treatment for the main cause of osteoporosis in women.
Because Osteoporosis does not occur in women, as long as their Hormonal Balance is excellent, Osteoporosis also does not exist when a woman’s Estrogen and Progesterone are in perfect harmony.
Types of Osteoporosis – symptoms.
Regardless of the age, any woman who’s Sex Hormones’ levels decline, that is, Estrogen and Progesterone, will experience a gradual decrease in bone mass, followed by Osteopenia and eventually Osteoporosis.
The types of osteoporosis are summarized as follows:
- Primary Osteoporosis, which contains
- Postmenopausal Osteoporosis – Premature Menopause
- Aging Osteoporosis
- Idiopathic Osteoporosis at a young age
- Secondary Osteoporosis, which develops as a result of a pre-existing disease, such as: Diabetes mellitus, Hyperparathyroidism, Hyperthyroidism, Cushing’s disease, Hypogonadism, Rheumatoid Arthritis, Absorption Syndrome, Multiple Myeloma, Sickle cell anemia. It can be also caused by a condition, such as prolonged physical immobilization of the patient and finally, Secondary Osteoporosis may occur after administration of certain corticosteroids or thyroid hormones during the treatment of hypothyroidism, etc.
We understand, therefore, that Disorders, Deficiencies, and imbalances in Hormone levels originate among other things, osteoporosis.
So the general view that there is no definitive cure for osteoporosis is wrong. On the contrary, the modern therapeutic approach is the answer to the main problem of Osteoporosis. That, includes obtaining a thorough medical history of all patient’s systems (Head to Toe) and individualized examinations (biochemical, hormonal, imaging, metabolic, etc.). Based on the above personalized approach, the possible malfunctions are detected and the existing deficiencies are identified.
The key is the detailed detection and treatment
Based on the results of laboratory and medical testing (Evidence Based Medicine) which are interpreted and analyzed precisely to the patient, the appropriate treatment is recommended, tailored to her own needs.
Detailed Osteoporosis Treatment and Restoration of Bone Mass.
There are multiple combinations of treatment regimens, which may include:
- Hormone Rehabilitation Treatments solely with Natural Hormones.
- Micro-Macronutrients Treatments
- Molecular Nutrition
With this therapeutic approach, we can achieve a gradual reverse of established bone loss in women and enhance restoration of the bone density. The sooner recovery begins ,the earlier a woman returns to an overall optimal level of health.
The treatment is adjusted each time, depending on the specific needs of each woman. There are no time limitations to the duration of this treatment approach, which also provides maximum anti-cancer protection.